Comparative Pharmacology
Head-to-head clinical analysis: TELDRIN versus ZADITOR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: TELDRIN versus ZADITOR.
TELDRIN vs ZADITOR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
TELDRIN contains loratadine and pseudoephedrine. Loratadine is a long-acting tricyclic antihistamine with selective peripheral H1-receptor antagonism. Pseudoephedrine is a sympathomimetic amine that acts as a decongestant by stimulating alpha-adrenergic receptors in the respiratory tract mucosa, causing vasoconstriction.
Selective histamine H1 receptor antagonist. Stabilizes mast cells, reducing release of histamine and other mediators of allergic response.
1-2 mg orally twice daily; maximum 4 mg/day.
1 drop in each affected eye twice daily, approximately 6-8 hours apart.
None Documented
None Documented
Terminal half-life: 9-12 hours (range 8-14) in healthy adults; prolonged in renal impairment.
Terminal elimination half-life is approximately 7 hours in adults, which supports twice-daily dosing for sustained ocular effects.
Renal: 55-60% unchanged; fecal: 35-40%; minor biliary elimination.
Primarily renal excretion as unchanged drug (approximately 30-40% of dose) and biliary/fecal elimination of metabolites (60-70%).
Category C
Category C
Antihistamine
Antihistamine